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Neuronal apoptosis induced by HIV-1 gp120 and the chemokine
SDF-1a is mediated by the chemokine receptor CXCR4
Joseph Hesselgesser*, Dennis Taub†, Padmavathi Baskar†, Michael
Greenberg‡, James Hoxie§, Dennis L. Kolson¶ and Richard Horuk*
CXCR4, a seven transmembrane domain G-protein-
coupled receptor for the Cys–X–Cys class of
chemokines, is one of several chemokine receptors that
can act as a co-receptor with CD4 for the human
immunodeficiency virus (HIV-1) glycoprotein gp120
[1–3]. CXCR4 can mediate the entry of HIV-1 strains
that specifically infect T cells, such as the IIIB strain
(see [4] for review). Recent reports indicate that gp120
can signal through CXCR4 [5] and it has been
suggested that signal transduction, mediated by the
viral envelope, might influence viral-associated
cytopathicity or apoptosis [6]. Neuronal apoptosis is a
feature of HIV-1 infection in the brain [7,8], although the
exact mechanism is unknown. Here, we address the
possible role of CXCR4 in inducing apoptosis using
cells of the hNT human neuronal cell line; these cells
resemble immature post-mitotic cholinergic neurons
and have a number of neuronal characteristics [9–15].
We have previously shown that gp120 from the HIV-1
IIIB strain binds with high affinity to CXCR4 expressed
on hNT neurons [15]. We now find that both IIIB gp120
and the Cys–X–Cys chemokine SDF-1a can directly
induce apoptosis in hNT neurons in the absence of CD4
and in a dose-dependent manner. To our knowledge,
this is the first report of a chemokine and an HIV-1
envelope glycoprotein eliciting apoptotic responses
through a chemokine receptor.
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Results and discussion
It has been shown that direct interactions between gp120
and neurons can induce apoptosis even in the absence of
macrophages/microglia [16,17]. A possible mechanism
could involve gp120 binding to chemokine receptors. To
address this issue, we looked at the effects of SDF-1α and
IIIB gp120 on the viability of pure cultures of hNT cells
rather than human fetal neuronal cultures, as the latter are
often contaminated with astrocytes and microglia. 
Initially, we examined neuronal cell viability by Trypan
Blue exclusion and saw between 40 and 60% cell leakage
and death. We further evaluated the ability of SDF-1α
and gp120 to induce neuronal cell death using several
assays including Tunel assays [18], lactate dehydrogenase
(LDH) release and nuclear matrix protein (NMP) forma-
tion. Apoptosis in hNT neurons was dependent on both
time and concentration when they were treated with
either IIIB gp120 or SDF-1α, as measured using the
Tunel assay (Figure 1a). SDF-1α at concentrations of
10–1000 nM induced apoptosis in 8–27% of cells by day 2
and 19–56% by day 5, whereas interleukin-8 (IL-8), a
Cys–X–Cys chemokine that is a functional ligand for these
cells but acts through the CXCR2 receptor, induced no
appreciable cell death over the same concentration ranges.
At concentrations of 8.3–207 nM, IIIB gp120 induced
apoptosis in 13–26% of cells by day 2 and 19–48% by day 5
(Figure 1a). This shows that although other chemokines
are functional for these cells through their cognate recep-
tors, only SDF-1α or IIIB gp120 were able to induce cell
death via CXCR4. As several reports have shown that Fas
and FasL are expressed on primary mouse fetal neurons
and human adult neurons [19,20], as a positive control we
tested the ability of anti-Fas monoclonal antibodies to
induce neuronal cell death. As shown in Figure 1a, the
death-inducing anti-Fas monoclonal antibody induced sig-
nificant cell death compared with a control isotype-
matched monoclonal antibody. Two other markers of cell
death — LDH release and NMP formation — were
assayed in hNT neurons after 5 days of treatment with
various concentrations of IIIB gp120 or SDF-1α. A dose-
dependent effect on neuronal cell death was observed for
both proteins in both assays (Figure 1b,d). These effects
were specific for CXCR4, as a monoclonal antibody to
CXCR4 could block the cell death induced by IIIB gp120
or SDF-1α (Figure 1c,e). Envelope gp120 proteins from
other strains of HIV that infect T cells, such as the BRU
and MN strains, gave similar LDH and NMP responses
with variable amounts of cell death (data not shown).
To support our findings that SDF-1α and IIIB gp120 can
specifically induce neuronal apoptosis via CXCR4 we
carried out cell migration experiments. We found that
hNT neurons stimulated with IIIB gp120 demonstrated a
potent (fourfold above control) chemotactic response
similar to that of SDF-1α (Figure 2). In addition, as previ-
ously shown [15], hNT neurons responded chemotacti-
cally to both IL-8 and SDF-1α but not to the related
Cys–X–Cys chemokine PF-4 (Figure 2). Whereas both
IL-8 and SDF-1α acting through their respective recep-
tors can induce migration of neurons, only SDF-1α and
IIIB gp120 were able to induce neuronal apoptosis
through activation of CXCR4. The effects of both
SDF-1α and IIIB gp120 were specific, as a monoclonal
antibody to CXCR4, 12G5, was able to block the migra-
tory response induced by SDF-1α and IIIB gp120 but not
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The viral glycoprotein IIIB gp120 and the chemokine SDF-1α induce
apoptosis in hNT cells. (a) Kinetic analysis, by Tunel assay, of
apoptosis of hNT neurons after SDF-1α or IIIB gp120 treatment. Cells
were treated with various chemokines, gp120, an anti-Fas monoclonal
antibody (MAb), or an isotype-matched monoclonal antibody control
(Ig) for 2 or 5 days in culture medium. Multiple fields (> 50 cells) were
counted on two slides from each of two experiments to derive the
proportion of apoptotic cells (± SEM) at each time point. (b) LDH
release from hNT cells treated with SDF-1α or IIIB gp120 after 5 days.
(c) Blocking of LDH release from hNT cells treated with SDF-1α or IIIB
gp120 by an anti-CXCR4 antibody (12G5). (d) NMP formation from
hNT cells treated with various concentrations of SDF-1α or IIIB gp120
after 5 days. (e) Blocking of NMP formation from hNT cells treated
with SDF-1α or IIIB gp120 by an anti-CXCR4 antibody. Cells were
treated for 5 days and cell-free supernatants assayed as described.
The response to IIIB gp120 at 125 nM in (b,c) varied between assays
because of variable amounts of CXCR4 expression on hNT neurons as
measured by immunohistochemistry and confocal microscopy (data
not shown). All experiments were carried out at least three times and
the mean ± SEM is shown for each value.
the IL-8 response (data not shown). Conversely, a neutral-
izing antibody to CXCR2 blocked the IL-8 migratory
response but not the SDF-1α or IIIB gp120 responses
(data not shown). These data also demonstrate for the first
time that a T-cell-tropic HIV-1 envelope protein, IIIB
gp120, can elicit a cellular response through the CXCR4
receptor in the absence of CD4.
At this point we do not know the mechanism(s) by which
IIIB gp120 and SDF-1α induce apoptosis in hNT neurons.
Preliminary experiments reveal that apoptosis via gp120 is
not due to increases in intracellular calcium or to induction
of glutamate uptake by functional glutamate (NMDA)
receptors (data not shown). As reported previously in other
cell types, however, we do find that SDF-1α can induce
calcium transients in hNT neurons (data not shown).
Further studies will be required to elucidate the nature of
the mechanisms by which CXCR4 is able to transduce
apoptotic signals in hNT neurons. This is important
because it is possible that these events also occur in primary
human neurons in the central nervous system (CNS). 
Incubation with low concentrations of gp120 in the pres-
ence of glial cells, or exposure to cell culture supernatants
from macrophages productively infected with HIV-1, has
also been shown to induce neuronal cell death [21]. It is
postulated that induction of neuronal apoptosis in HIV-1
infection results from indirect effects of such exposure
through the release of glutamate and/or other neurotoxins
from neighboring glial cells, which in turn act upon gluta-
mate receptors on the neurons [22]. It has been suggested
that gp120 at areas of viral infection, replication, gp120 cell-
surface expression and envelope shedding, may be much
higher than those measurable in the circulation [23–25].
Thus, although local ‘hot spots’ of gp120 within the CNS
have not so far been demonstrated in vivo, overexpression
of gp120 in the brains of transgenic mice does correlate with
neuronal dysfunction and cellular destruction [24,26,27]. 
The loss of large pyramidal neurons has been reported in
previous work on the effects of overexpressing gp120 in
the CNS of transgenic mice [27]. Exposure of non-trans-
genic hippocampal neurons with the gp120-transgenic
glial cultures resulted in neurotoxic changes consistent
with soluble gp120 or microglial/astrocytic cellular meta-
bolites [27]. Similar losses of a subset of neurons in the
CA3 region of the hippocampus have also been seen in
HIV-infected human brains [28]. These large pyramidal
cells are the specific subset of hippocampal neurons that
express CXCR4 [29] and it is possible that direct interac-
tions with soluble gp120 from T-cell-tropic HIV strains
may lead to aberrant neuronal function or neuronal drop-
out as seen in CNS AIDS [28,30]. 
The fact that CXCR4 is expressed in human CNS
neurons [29], taken together with our previous findings
that gp120 binds to CXCR4 on hNT neurons [15] and our
present findings demonstrating gp120-induced apoptosis
in hNT neurons, suggests it is possible that the neuronal
destruction observed in HIV-1 infection of the CNS could
in part be due to direct effects of gp120 mediated through
CXCR4. As the evolution of T-cell-tropic strains of HIV
tends to occur during the late stages of AIDS, when neu-
rological symptoms typically appear, our finding that the
binding of T-cell-tropic gp120 to CXCR4 can induce neu-
ronal apoptosis raises the possibility that this might occur
in pediatric AIDS and AIDS dementia.
Materials and methods
Viral envelopes and chemokines
Recombinant IIIB gp120 expressed in insect cells was from ICN
(Costa Mesa). This specific IIIB gp120 binds to CD4+ cells, inhibits
syncytia formation and reacts with HIV+ patient sera in western blots
[31,32]. IIIB gp120 was tested for purity by amino acid composition
analysis and was not found to contain any contaminants, including
chemokines. All chemokines were from Peprotech (Rocky Hill).
Cell culture, chemotaxis and cell viability assays
Human hNT neurons were induced from NTera2 cells and maintained
as described previously [15]; hNT cell migration was examined using a
48-well microchemotaxis assay as previously described [15]. Cell
death was assessed by DNA fragmentation using the Tunel assay [18].
Human hNT neurons (5 × 103 per well) were plated on sterile laminin-
coated chamber (glass) slides for 24 h in culture medium (containing
2% human serum). After attachment and spreading, the hNT cells were
treated with SDF-1α or IL-8 (0.01–1 µM), IIIB gp120 (8.3–207 nM), or
anti-Fas monoclonal antibody (67 nM, CH11) for 2–5 days. Following
incubation, the percentage viability of the hNT cells was assessed by
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Figure 2
SDF-1α and HIV-1 IIIB gp120 induce hNT cell migration on laminin-
coated filters. The graph shows the rate of chemotaxis of human hNT
neurons in response to the Cys–X–Cys chemokines IL-8, SDF-1α and
PF-4 and to the HIV-1 envelope protein IIIB gp120; HPFs, high
powered fields. The mean ± SEM of three experiments is shown.
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Trypan Blue and the Tunel assay as described previously [18]. For LDH
and NMP assays, hNT cells were treated for 5 days with various con-
centrations of SDF-1α, IL-8, IIIB gp120 or antibodies. Cell-free super-
natants were harvested and analyzed for LDH and NMP release. The
NMP ELISA assay was carried out according to the manufacturers’
instructions (Calbiochem).
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